Nuoling Biomedical Technology (Beijing) Co., Ltd.
诺灵生物
Nuoling Biomedical Technology (Beijing) Co., Ltd.
Biotech/Healthcare
Noling Biopharmaceutical is a biotechnology company focused on developing anticancer technologies. It specializes in a next-generation antibody–drug conjugate (ADC) platform and the research, development, and design of innovative ADC drugs based on this platform.
Latest round: Series B (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.